Fate Therapeutics Inc. buy Wedbush
Start price
27.10.25
/
50%
€1.35
Target price
27.10.26
€6.02
Performance (%)
102.97%
Price
10.07.26
€2.73
Summary
This prediction is currently active. The BUY prediction by Wedbush for Fate Therapeutics Inc. has seen massive gains of 102.97%. This prediction currently runs until 27.10.26. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Fate Therapeutics Inc. | 6.975% | 6.975% |
| iShares Core DAX® | -2.680% | 4.261% |
| iShares Nasdaq 100 | 0.725% | 5.796% |
| iShares Nikkei 225® | -0.725% | 9.319% |
| iShares S&P 500 | 1.166% | 5.479% |
Comments by Wedbush for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics (NASDAQ:FATE) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $7.00 price target on the stock, up previously from $5.00.
Ratings data for FATE provided by MarketBeat